GO
Loading...

Valeant CEO: Allergan has a great set of assets

Wednesday, 23 Apr 2014 | 7:33 AM ET

J. Michael Pearson, Valeant Pharmaceuticals chairman & CEO, explains why he decided to pursue Allergan and shares his R&D business model, with CNBC's Kate Kelly. This year we are launching 19 products in the United States, says Pearson.